Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Alcoholism: Clinical and Experimental Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1530-0277.2012.01901.xPMID 22827451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development.

  2012cited by this paper
• Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.

  2011cited by this paper
• Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.

  2011cited by this paper
• Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies

  2011cited by this paper
• Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.

  2010cited by this paper
• Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells

  2010cited by this paper
• Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1

  2010cited by this paper
• Impact of drug transporters on cellular resistance towards saquinavir and darunavir.

  2010cited by this paper
• Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests

  2010cited by this paper
• Chemokines in Liver Inflammation and Fibrosis

  2010cited by this paper
• Liver stiffness: a novel parameter for the diagnosis of liver disease

  2010cited by this paper
• Liver stiffness is directly influenced by central venous pressure.

  2010cited by this paper
• Pathogenesis of alcoholic liver disease: the role of nuclear receptors

  2010cited by this paper
• Regulationofhumanhepatic drugtransporterexpressionby pro-inflammatorycytokines

  2009cited by this paper
• Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines

  2009cited by this paper
• Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

  2008influential reference
• Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

  2008cited by this paper
• Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2008cited by this paper
• Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory tests

  2008cited by this paper
• Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients

  2008cited by this paper
• Pharmacokinetics and dosage adjustment in patients with renal dysfunction

  2008influential reference
• Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.

  2007cited by this paper
• Dosage adjustment for hepatic dysfunction based on Child-Pugh scores.

  2007cited by this paper
• ERSPECTIVES IN CLINICAL HARMACOLOGY rug interactions with lipid-lowering rugs : Mechanisms and clinical relevance

  2006cited by this paper
• Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance

  2006cited by this paper
• [Epidemiology and natural history of cirrhosis].

  2005cited by this paper
• Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

  2005influential reference
• The Hepatic Sinusoid in Aging and Cirrhosis

  2005influential reference
• Transporters and drug therapy: Implications for drug disposition and disease

  2005cited by this paper
• Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: A comparison with nonalcoholics

  2005cited by this paper
• Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

  2003cited by this paper
• Induction of CYP3A by ethanol in multiple in vitro and in vivo models.

  2003cited by this paper
• Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.

  2003cited by this paper
• Chemokines in liver inflammation and fibrosis.

  2002cited by this paper
• Alteration of drug biotransformation and elimination during infection and inflammation.

  2001cited by this paper
• Psychotic manifestations of alcoholism

  2001cited by this paper
• Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.

  1999cited by this paper
• Clinical and toxicological consequences of the inductive potential of ethanol

  1998cited by this paper
• CYP2E1 activity in patients with alcoholic liver disease.

  1997cited by this paper
• The effect of liver disease on urine caffeine metabolite ratios

  1996cited by this paper
• Medical disorders of alcoholism.

  1995cited by this paper
• Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment.

  1995influential reference
• Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes.

  1995cited by this paper
• Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.

  1994cited by this paper
• Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.

  1994cited by this paper
• Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.

  1993cited by this paper
• Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers

  1988cited by this paper
• Ethanol as enzyme inducer and inhibitor.

  1987cited by this paper
• Thiopentone pharmacokinetics in patients with chronic alcoholism.

  1984cited by this paper
• Benzodiazepines and Ethanol: Assessment of the Effects and Consequences of Psychotropic Drug Interactions

  1982cited by this paper
• Effect of short‐ and long‐term alcohol use on phenytoin kinetics in chronic alcoholics

  1981cited by this paper
• Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in man.

  1976cited by this paper
• Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats.

  1971cited by this paper
• Analytical investigations of barbiturate poisoning--description of methods and a survey of results.

  1967cited by this paper

• Statins in Chronic Liver Disease: Review of the Literature and Future Role

  2024cites this paper
• A Unification of Nanotopography and Extracellular Matrix in Electrospun Scaffolds for Bioengineered Hepatic Models

  2023cites this paper
• The Role of Statins in Cirrhosis

  2022cites this paper
• Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy

  2021cites this paper
• Development of Scaffolds with Adjusted Stiffness for Mimicking Disease-Related Alterations of Liver Rigidity

  2020cites this paper
• Towards improved hepatocyte cultures: Progress and limitations.

  2020cites this paper
• Cirrhosis as new indication for statins

  2020cites this paper
• The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis

  2018cites this paper
• A Standardized Collagen-Based Scaffold Improves Human Hepatocyte Shipment and Allows Metabolic Studies over 10 Days

  2018cites this paper
• Isoform-Dependent Changes in Cytochrome P450-Mediated Drug Metabolism after Portal Vein Ligation in the Rat

  2018cites this paper
• Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance.

  2016cites this paper
• Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

  2016cites this paper
• Statins: the Panacea of Cirrhosis?

  2016cites this paper
• Diagnostic challenges in alcohol use disorder and alcoholic liver disease.

  2014cites this paper
• Expression of P450 and nuclear receptors in normal and end-stage Chinese livers.

  2014cites this paper
• In‐vitro evaluation of chronic alcohol effects on expression of drug‐metabolizing and drug‐transporting proteins

  2013cites this paper
• Assessment of renal allograft fibrosis by transient elastography

  2013cites this paper